Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S; ITA-COVID-19: RAAS inhibitor group. Trifirò G, et al. Among authors: crisafulli s. Drug Saf. 2020 Dec;43(12):1297-1308. doi: 10.1007/s40264-020-00994-5. Drug Saf. 2020. PMID: 32852721 Free PMC article.
Pharmacokinetics of new oral anticoagulants: implications for use in routine care.
Ingrasciotta Y, Crisafulli S, Pizzimenti V, Marcianò I, Mancuso A, Andò G, Corrao S, Capranzano P, Trifirò G. Ingrasciotta Y, et al. Among authors: crisafulli s. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1057-1069. doi: 10.1080/17425255.2018.1530213. Expert Opin Drug Metab Toxicol. 2018. PMID: 30277082 Review.
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case study.
Crisafulli S, Sultana J, Ingrasciotta Y, Addis A, Cananzi P, Cavagna L, Conter V, D'Angelo G, Ferrajolo C, Mantovani L, Pastorello M, Scondotto S, Trifirò G. Crisafulli S, et al. Expert Opin Drug Saf. 2019 Jun;18(6):497-509. doi: 10.1080/14740338.2019.1614165. Epub 2019 May 22. Expert Opin Drug Saf. 2019. PMID: 31059293 Review.
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
Trifirò G, Crisafulli S, Andò G, Racagni G, Drago F; Italian Society of Pharmacology. Trifirò G, et al. Among authors: crisafulli s. Drug Saf. 2020 Jun;43(6):507-509. doi: 10.1007/s40264-020-00935-2. Drug Saf. 2020. PMID: 32303915 Free PMC article. No abstract available.
Challenges for Drug Repurposing in the COVID-19 Pandemic Era.
Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S, Trifirò G. Sultana J, et al. Among authors: crisafulli s. Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020. Front Pharmacol. 2020. PMID: 33240091 Free PMC article. Review.
Real World Use of Antidiabetic Drugs in the Years 2011-2017: A Population-Based Study from Southern Italy.
Ingrasciotta Y, Bertuccio MP, Crisafulli S, Ientile V, Muscianisi M, L'Abbate L, Pastorello M, Provenzano V, Scorsone A, Scondotto S, Trifirò G. Ingrasciotta Y, et al. Among authors: crisafulli s. Int J Environ Res Public Health. 2020 Dec 18;17(24):9514. doi: 10.3390/ijerph17249514. Int J Environ Res Public Health. 2020. PMID: 33353081 Free PMC article.
59 results